Bringing Together Efficacy and Safety Testing in Cancer Drug Development
Posted on September 13, 2019
Paul S. Jones,
Preclinical Sciences Manager
Cancer Research UK
Introduction The development of new anti-cancer drugs is undergoing a radical shift as molecular biological techniques become adopted as an integral part of translational medicine1. Agents have become more targeted, their targets better characterised, the molecular vulnerabilities of tumours better...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
Cancer Drug Development, efficacy studies, molecular biological techniques, Safety Testing, toxicity studies
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
